Search

Search Constraints

You searched for: Author/Creator Hashmi, Syed

Search Results

12. Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2–3 trial. Issue 2 (February 2023)